Promptus accelerates the commercialization of healthcare intellectual property through an operator-led platform. It uses AI to identify promising IP, de-risks development with capital-efficient financing, and streamlines regulatory clearance and market entry to deliver acquisition-ready products within 18-30 months.
Funding
Funding not disclosed
Founders
Product
Problem
A significant volume of healthcare intellectual property (IP) remains underutilized within academic and hospital technology transfer offices. A substantial portion of viable IP fails to progress through the startup pipeline, hindering its adoption and delaying patient access to novel medical technologies. The typical timeline for bringing healthcare innovations to market is excessively long, often spanning 7-10 years.
Solution
Promptus operates an Expedited Innovation Platform (EIP) designed to accelerate the commercialization of healthcare IP. The platform employs an operator-led, capital-efficient model to de-risk the innovation process and expedite product development, regulatory clearance, and market entry. Through AI-driven IP analysis, Promptus identifies promising technologies with clear regulatory pathways and potential acquirers. The EIP manages the entire lifecycle from IP acquisition and financing via milestone-based SPVs, through rapid design, prototyping, and validation, to streamlined FDA 510(k) clearance and strategic exit positioning with pre-identified buyers. This structured approach aims to deliver acquisition-ready products within an 18-30 month timeframe.
Target Audience
The primary customers are universities, hospitals, and research laboratories seeking to commercialize their intellectual property, as well as healthcare innovators and investors looking for efficient pathways to market.
Features
- AI-driven analysis for IP identification, patent strength assessment, and buyer marketability.
- Structured IP acquisition and protection protocols.
- Milestone-based Special Purpose Vehicles (SPVs) for capital-efficient project financing.
- Dedicated teams for rapid design, prototyping, and validation of medical technologies.
- Integrated checkpoints to streamline FDA 510(k) clearance processes.
- Strategic positioning for accelerated acquisition by pre-identified market buyers.
- Physician Advisory Network for clinical validation and market insight integration.